1151P Evolution of biomarker testing among non-squamous/non-small cell lung cancer (NSCLC) patients (Pts) and impact on turnaround times (TAT)

Zixin Fan; R. Tudor; L. Le; J. Law; S. Kuang; N. Meti; A. Fung; K. Perdrizet; K. Chen; J. Li; N. Ghumman; L. Ranich; C. Wei; P. Sabatani; M-S. Tsao; N. Leighl; M. Cabanero

doi:10.1016/j.annonc.2022.07.1275

1151P Evolution of biomarker testing among non-squamous/non-small cell lung cancer (NSCLC) patients (Pts) and impact on turnaround times (TAT)

Zixin Fan(University Health Network), R. Tudor(University Health Network), L. Le(University Health Network), J. Law(University Health Network), S. Kuang(BC Cancer Agency), N. Meti(St Mary's Hospital Centre), A. Fung(Kingston Health Sciences Centre), K. Perdrizet(Brampton Civic Hospital), K. Chen(University Health Network), J. Li(University Health Network), N. Ghumman(University Health Network), L. Ranich(Toronto General Hospital), C. Wei(Toronto General Hospital), P. Sabatani(Toronto General Hospital), M-S. Tsao(University Health Network), N. Leighl(University Health Network), M. Cabanero(University Health Network)

Annals of Oncology

September 1, 2022

10.1016/j.annonc.2022.07.1275

Cited by 0

Abstract

Related Papers

No related papers found

Powered by citation graph analysis